Mallinckrodt plc and Endo, Inc. (NDOI) have secured the necessary shareholder approvals to proceed with their merger, a stock-and-cash transaction aimed at forming a global, diversified pharmaceutical leader.
With this approval, Mallinckrodt will now seek confirmation of the scheme of arrangement from the Irish High Court, with a sanction hearing expected in July. Subject to court approval and other closing conditions, the companies aim to finalise the merger shortly after the hearing. The combined entity will have its global headquarters in Dublin, Ireland.
Friday NDOI closed at $20.9 or 1.65% lower on the OTC Markets OTCQX.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.